awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37602657-050899BC-51AB-4176-83C6-21B25557FF81
Q37602657-050899BC-51AB-4176-83C6-21B25557FF81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37602657-050899BC-51AB-4176-83C6-21B25557FF81
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
P50
Q37602657-050899BC-51AB-4176-83C6-21B25557FF81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37602657-050899BC-51AB-4176-83C6-21B25557FF81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5564f064a31eba268f7a99393e255144870ad02c
P1545
10
http://www.w3.org/2001/XMLSchema#string
P1932
Keith T Flaherty
http://www.w3.org/2001/XMLSchema#string
P50
Keith Flaherty